Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent protection nicardipine?How has the market responded to apotex's launch of generic ruxolitinib?Apalutamide fda exclusivity date?Azulfidine en tabs price?Lupron depot patent excipient?
See the DrugPatentWatch profile for Keytruda
Keytruda (pembrolizumab) received its first FDA approval in 2014. [1]
That 2014 date refers to Keytruda’s initial FDA approval. After that, the FDA approved additional indications in later years as new clinical results supported them. [1]
[1] https://www.drugpatentwatch.com/portfolio/keytruda-pembrolizumab/
Other Questions About Keytruda :